mitomycin has been researched along with fotemustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabian, K; Kaina, B; Thacker, J; Tsaryk, R | 1 |
| Bessoud, B; De Baere, T; Denys, A; Doenz, F; Proietti, S; Qanadli, SD; Schnyder, P | 1 |
| Anastassiou, G; Bornfeld, N; Freistuehler, M; Hilger, RA; Nareyeck, G; Scheulen, ME; Steuhl, KP; Westekemper, H; Zeschnigk, M | 1 |
3 other study(ies) available for mitomycin and fotemustine
| Article | Year |
|---|---|
Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cisplatin; Cyclophosphamide; Dacarbazine; DNA-Binding Proteins; Humans; Methylnitronitrosoguanidine; Mitomycin; Mutagens; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide | 2006 |
Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Duodenal Ulcer; Duodenum; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Female; Femoral Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Nitrosourea Compounds; Organophosphorus Compounds; Organoplatinum Compounds; Oxaliplatin; Stomach; Stomach Ulcer; Treatment Outcome | 2007 |
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Nitrosourea Compounds; Organophosphorus Compounds; Tretinoin | 2011 |